This inventor holds 1 USPTO granted patent, plus 4 CIPO patents and 3 EPO patents. Top assignee: Ablynx N.v.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovations of Els Beirnaert
Introduction
Els Beirnaert is a notable inventor based in Bellem, Belgium. She has made significant contributions to the field of biochemistry, particularly in the development of serum albumin binding proteins. Her work has implications for pharmaceutical compositions and therapeutic applications.
Latest Patents
Els Beirnaert holds a patent related to serum albumin binding proteins. The invention involves amino acid sequences capable of binding to serum albumin without significantly reducing its binding to FcRn or its half-life. This patent encompasses proteins and polypeptides that include these amino acid sequences, as well as nucleic acids that encode them. Additionally, it covers compositions, particularly pharmaceutical ones, that utilize these sequences and their applications.
Career Highlights
Els Beirnaert is associated with Ablynx N.V., a company known for its innovative approaches in biopharmaceuticals. Her work at Ablynx has positioned her as a key player in the development of novel therapeutic solutions.
Collaborations
Els has collaborated with notable colleagues, including Hilde Adi Pierrette Revets and Hendricus Renerus Jacobus Mattheus Hoogenboom. These collaborations have further enhanced her research and contributions to the field.
Conclusion
Els Beirnaert's innovative work in serum albumin binding proteins showcases her expertise and commitment to advancing biopharmaceutical research. Her contributions are significant in the development of new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile